Literature DB >> 17337070

Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Min Li1, Patrick L Green.   

Abstract

HTLV-1 and HTLV-2 are highly related delta-retroviruses that infect and transform T-lymphocytes, but have distinct pathogenic properties. HTLV replication and survival requires the expression of multiple gene products from an unspliced and a series of highly related alternatively spliced mRNA species. To date, the comparative levels of all known HTLV-1 and HTLV-2 viral mRNAs in different transformed cell lines and at different stages of virus infection have not been assessed. In this study, we compiled a series of oligonucleotide primer pairs and probes to quantify both HTLV-1 and HTLV-2 mRNA species using real-time RT-PCR. The optimized reaction for detection of each mRNA had amplification efficiency greater than 90% with a linear range spanning 25-2.5 x 10(7) copies. The R(2)'s of all standard curves were greater than 0.97. Quantitation of HTLV mRNAs between different cell lines showed variability (gag/pol>or=tax/rex>env>or=accessory proteins), but the overall levels of each mRNA relative to each other within a cell line were similar. These results provide a method to quantify all specific mRNAs from both HTLV-1 and HTLV-2, which can be used to evaluate further viral gene expression and correlate transcript levels to key stages of the virus life cycle and ultimately, pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17337070      PMCID: PMC2048902          DOI: 10.1016/j.jviromet.2007.01.023

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  62 in total

1.  Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.

Authors:  M Shuh; S A Hill; D Derse
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

Review 2.  The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level.

Authors:  Diane R Wycuff; Susan J Marriott
Journal:  Front Biosci       Date:  2005-01-01

Review 3.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

4.  Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II.

Authors:  V Ciminale; D M D'Agostino; L Zotti; G Franchini; B K Felber; L Chieco-Bianchi
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

Review 5.  Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.

Authors:  A J Lopez
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

6.  HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.

Authors:  Jun Matsumoto; Takayuki Ohshima; Osamu Isono; Kunitada Shimotohno
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

7.  Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs.

Authors:  K Kusuhara; M Anderson; S M Pettiford; P L Green
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions.

Authors:  Soumya Awasthi; Anima Sharma; Kasuen Wong; Junyu Zhang; Elizabeth F Matlock; Lowery Rogers; Pamela Motloch; Shigeki Takemoto; Hirokuni Taguchi; Michael D Cole; Bernhard Lüscher; Oliver Dittrich; Hideaki Tagami; Yoshihiro Nakatani; Monnie McGee; Anne-Marie Girard; Luke Gaughan; Craig N Robson; Raymond J Monnat; Robert Harrod
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

10.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

View more
  28 in total

1.  Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.

Authors:  Priya Kannian; Han Yin; Rami Doueiri; Michael D Lairmore; Soledad Fernandez; Patrick L Green
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Human T lymphotropic virus type 1 regulatory and accessory gene transcript expression and export are not rex dependent.

Authors:  Min Li; Priya Kannian; Han Yin; Matthew Kesic; Patrick L Green
Journal:  AIDS Res Hum Retroviruses       Date:  2011-08-05       Impact factor: 2.205

3.  Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo.

Authors:  Han Yin; Priya Kannian; Nathan Dissinger; Robyn Haines; Stefan Niewiesk; Patrick L Green
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.

Authors:  Masao Nakagawa; Arthur L Shaffer; Michele Ceribelli; Meili Zhang; George Wright; Da Wei Huang; Wenming Xiao; John Powell; Michael N Petrus; Yibin Yang; James D Phelan; Holger Kohlhammer; Sigrid P Dubois; Hee Min Yoo; Emmanuel Bachy; Daniel E Webster; Yandan Yang; Weihong Xu; Xin Yu; Hong Zhao; Bonita R Bryant; Joji Shimono; Takashi Ishio; Michiyuki Maeda; Patrick L Green; Thomas A Waldmann; Louis M Staudt
Journal:  Cancer Cell       Date:  2018-07-26       Impact factor: 31.743

5.  Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells.

Authors:  Héloïse Macaire; Aurélien Riquet; Vincent Moncollin; Marie-Claude Biémont-Trescol; Madeleine Duc Dodon; Olivier Hermine; Anne-Laure Debaud; Renaud Mahieux; Jean-Michel Mesnard; Marlène Pierre; Louis Gazzolo; Nathalie Bonnefoy; Hélène Valentin
Journal:  J Biol Chem       Date:  2012-05-02       Impact factor: 5.157

6.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

7.  Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.

Authors:  Joshua Arnold; Bevin Zimmerman; Min Li; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

Review 8.  Multiple facets of junD gene expression are atypical among AP-1 family members.

Authors:  J M Hernandez; D H Floyd; K N Weilbaecher; P L Green; K Boris-Lawrie
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

9.  An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ.

Authors:  Isabelle Clerc; Nicholas Polakowski; Charlotte André-Arpin; Pamela Cook; Benoit Barbeau; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

Review 10.  The HBZ gene, a key player in HTLV-1 pathogenesis.

Authors:  Masao Matsuoka; Patrick L Green
Journal:  Retrovirology       Date:  2009-08-03       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.